Long term results of a Multicenter study of autologous selected-PBSC transplantation in advanced CLL patients.
2002-01-01 Scime, R; Tringali, S; Santoro, A; Di Bella, R; Cavallaro, A; Majolino, I; Musso, M; Olivieri, Attilio; Narni, F; Iacopino, P; Leoni, Pietro; Basirico, R; Mirto, S.
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis.
2002-01-01 Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, M; Musso, M; Callea, V; Gallamini, A; Patti, C; Pavone, V; Almici, C; Di Raimondo, F; Fioritoni, G; Olivieri, Attilio; Pogliani, Em; De Souza, Ca; Majolino, I; Boccadoro, M; Gianni, Am; Pileri, A; Corradini, P; Tarella, C.
Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma.
2002-01-01 Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M.
Reduced-intensity conditioning followed by allogeneic transplantation (HSCT) is an effective salvage treatment for both low- and high-grade non-Hodgkin lymphomas: Disease chemosensitivity has a major impact on outcome.
2002-01-01 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, Em; Rambaldi, A; Majolino, I; Soligo, D; Scime, R; Gianni, Am
Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need.
2002-01-01 Olivieri, Attilio; Spitaleri, L; Gini, G; Montanari, M; Capelli, D; Lucesole, M; Scortechini, I; Poloni, Antonella; Pasquini, R; Masia, Mc; Leoni, Pietro
Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG
2003-01-01 Santini, G; Olivieri, Attilio; Majolino, I; Congiu, A; Chisesi, T; De Souza, C; Patti, C; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V.
Long-term results of a multicenter study of autologous selected PBSC transplantation in advanced CLL patients
2003-01-01 Scime, R; Tringali, S; Santoro, A; Cavallaro, A; Musso, M; Basirico, R; Di Bella, R; Indovina, A; Crescimanno, A; Olivieri, Attilio; Donelli, A.
In multiple myeloma (MM) allogeneic PBSC transplantation results in high rate of remission and low rate of recurrence.
2002-01-01 Majolino, I; Corradini, P; Santoro, A; Scime, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marceno, R; Pileri, A.
Kinetics of immune reconstitution and incidence of infections following allogeneic peripheral blood stem cell transplantation (PBSCT) in patients conditioned with a reduced-intensity regimen
2002-01-01 Dodero, A; Peccatori, J; Olivieri, Attilio; Pescarollo, A; Ferreri, A; Rossini, S; Gianni, Am; Bordignon, C; Bregni, M; Corradini, P.
Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation
2003-01-01 Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio
An outpatient model of autologous stem cell transplantation with double peripheral blood stem cell reinfusion and early growth factor administration
2003-01-01 Olivieri, Attilio; Montanari, M; Capelli, D; Lucesole, M; Spitaleri, L; Scortechini, I; Cecchi, S; Gini, G; Leoni, Pietro
Chimerism evaluation in the lymphoemopoietic subpopulation after allogeneic reduced-intensity stem cell transplantation: a comparison of two different regimens including and not fludarabine
2003-01-01 Lucesole, M; Poloni, Antonella; Capelli, D; Gini, G; Spitaleri, L; Cecchi, S; Montanari, M; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate
2003-01-01 Ladetto, M; Ricca, I; Benedetti, F; Liberati, M; Vitolo, U; Musso, M; Gallamini, A; Callea, V; Pavone, V; Almici, C; Di Raimondo, F; De Sousa, C; Fioritoni, G; Majolino, I; Olivieri, Attilio; Patti, C; Pogliani, E; Astolfi, M; Boccadoro, M; Gianni, Am; Corradini, P; Tarella, C.
Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma
2003-01-01 Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, E; Rambaldi, A; Locasciulli, A; Falda, M; Santoro, A; Scime, R; Gianni, Am
Combination therapy with Caelyx, dexamethasone and thalidomide (CDT) for multiple myeloma (MM): Preliminary results of a phase II-III study.
2003-01-01 Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Barulli, S; Capelli, D; Rupoli, S; Leoni, Pietro
Reduction of the aplastic phase and hospitalization in patients receiving PBSC autotransplantation followed by erythropoietin plus filgrastim: A matched analysis of 79 consecutive procedures
2003-01-01 Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Cecchi, S; Spitaleri, L; Troiani, E; Masia, Mc; Leoni, Pietro
Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine.
2003-01-01 Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio
Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma.
2003-01-01 Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P.
In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease.
2003-01-01 Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P.
Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease
2004-01-01 Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long term results of a Multicenter study of autologous selected-PBSC transplantation in advanced CLL patients. | 1-gen-2002 | Scime, R; Tringali, S; Santoro, A; Di Bella, R; Cavallaro, A; Majolino, I; Musso, M; Olivieri, Attilio; Narni, F; Iacopino, P; Leoni, Pietro; Basirico, R; Mirto, S. | |
| Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with Rituximab as frontline therapy for high-risk follicular lymphoma (FL) patients: An interim analysis. | 1-gen-2002 | Ladetto, M; Ricca, I; Benedetti, F; Vitolo, U; Liberati, M; Musso, M; Callea, V; Gallamini, A; Patti, C; Pavone, V; Almici, C; Di Raimondo, F; Fioritoni, G; Olivieri, Attilio; Pogliani, Em; De Souza, Ca; Majolino, I; Boccadoro, M; Gianni, Am; Pileri, A; Corradini, P; Tarella, C. | |
| Reduced-intensity conditioning with low dose ATG or alemtuzumab followed by allogeneic PBSC: A salvage therapy with an encouraging response rate and limited toxicity in relapsed/refractory multiple myeloma. | 1-gen-2002 | Corradini, P; Milani, R; Ciceri, F; Montefusco, V; Peccatori, J; Mariotti, J; Olivieri, Attilio; Soligo, D; Gianni, Am; Perfetti, V; Bregni, M. | |
| Reduced-intensity conditioning followed by allogeneic transplantation (HSCT) is an effective salvage treatment for both low- and high-grade non-Hodgkin lymphomas: Disease chemosensitivity has a major impact on outcome. | 1-gen-2002 | Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, Em; Rambaldi, A; Majolino, I; Soligo, D; Scime, R; Gianni, Am | |
| Double reinfusion of PBPC after autotransplantation, combined with early G-CSF plus EPO administration, significantly shortens the cytopenia and abolish the transfusional need. | 1-gen-2002 | Olivieri, Attilio; Spitaleri, L; Gini, G; Montanari, M; Capelli, D; Lucesole, M; Scortechini, I; Poloni, Antonella; Pasquini, R; Masia, Mc; Leoni, Pietro | |
| Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG | 1-gen-2003 | Santini, G; Olivieri, Attilio; Majolino, I; Congiu, A; Chisesi, T; De Souza, C; Patti, C; Salvagno, L; Quaini, R; Rubagotti, A; Centurioni, R; Contu, A; Candela, M; Rizzoli, V. | |
| Long-term results of a multicenter study of autologous selected PBSC transplantation in advanced CLL patients | 1-gen-2003 | Scime, R; Tringali, S; Santoro, A; Cavallaro, A; Musso, M; Basirico, R; Di Bella, R; Indovina, A; Crescimanno, A; Olivieri, Attilio; Donelli, A. | |
| In multiple myeloma (MM) allogeneic PBSC transplantation results in high rate of remission and low rate of recurrence. | 1-gen-2002 | Majolino, I; Corradini, P; Santoro, A; Scime, R; Falda, M; Bosi, A; Tarella, C; Musso, M; Olivieri, Attilio; Boccadoro, M; Marceno, R; Pileri, A. | |
| Kinetics of immune reconstitution and incidence of infections following allogeneic peripheral blood stem cell transplantation (PBSCT) in patients conditioned with a reduced-intensity regimen | 1-gen-2002 | Dodero, A; Peccatori, J; Olivieri, Attilio; Pescarollo, A; Ferreri, A; Rossini, S; Gianni, Am; Bordignon, C; Bregni, M; Corradini, P. | |
| Salvage therapy with pegylated lyposomal doxorubicin and rituximab plus GM-CSF in heavily pretreated lymphoma patients relapsing after transplantation | 1-gen-2003 | Lucesole, M; Capelli, D; Montanari, M; Gini, G; Cecchi, S; Spitaleri, L; Poloni, Antonella; Leoni, Pietro; Olivieri, Attilio | |
| An outpatient model of autologous stem cell transplantation with double peripheral blood stem cell reinfusion and early growth factor administration | 1-gen-2003 | Olivieri, Attilio; Montanari, M; Capelli, D; Lucesole, M; Spitaleri, L; Scortechini, I; Cecchi, S; Gini, G; Leoni, Pietro | |
| Chimerism evaluation in the lymphoemopoietic subpopulation after allogeneic reduced-intensity stem cell transplantation: a comparison of two different regimens including and not fludarabine | 1-gen-2003 | Lucesole, M; Poloni, Antonella; Capelli, D; Gini, G; Spitaleri, L; Cecchi, S; Montanari, M; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio | |
| Multicenter prospective randomized GITMO trial comparing high dose sequential chemotherapy with autografting and CHOP both supplemented with rituximab in poor-risk follicular lymphoma: early evaluation on treatment feasibility and response rate | 1-gen-2003 | Ladetto, M; Ricca, I; Benedetti, F; Liberati, M; Vitolo, U; Musso, M; Gallamini, A; Callea, V; Pavone, V; Almici, C; Di Raimondo, F; De Sousa, C; Fioritoni, G; Majolino, I; Olivieri, Attilio; Patti, C; Pogliani, E; Astolfi, M; Boccadoro, M; Gianni, Am; Corradini, P; Tarella, C. | |
| Reduced-intensity conditioning followed by allogeneic transplantation can produce clinical and molecular remissions in relapsed non-Hodgkin's lymphoma | 1-gen-2003 | Corradini, P; Bregni, M; Tarella, C; Olivieri, Attilio; Dodero, A; Farina, L; Zallio, F; Leoni, Pietro; Ciceri, F; Devizzi, L; Benedetti, F; Pogliani, E; Rambaldi, A; Locasciulli, A; Falda, M; Santoro, A; Scime, R; Gianni, Am | |
| Combination therapy with Caelyx, dexamethasone and thalidomide (CDT) for multiple myeloma (MM): Preliminary results of a phase II-III study. | 1-gen-2003 | Offidani, M; Marconi, M; Corvatta, L; Malerba, L; Olivieri, Attilio; Barulli, S; Capelli, D; Rupoli, S; Leoni, Pietro | |
| Reduction of the aplastic phase and hospitalization in patients receiving PBSC autotransplantation followed by erythropoietin plus filgrastim: A matched analysis of 79 consecutive procedures | 1-gen-2003 | Olivieri, Attilio; Scortechini, I; Capelli, D; Montanari, M; Lucesole, M; Gini, G; Cecchi, S; Spitaleri, L; Troiani, E; Masia, Mc; Leoni, Pietro | |
| Lymphoemopoietic chimerism after non myeloablative stem cell transplantation (NST): Comparison between two different regimens including and not including fludarabine. | 1-gen-2003 | Lucesole, M; Poloni, Antonella; Capelli, D; Montanari, M; Cecchi, S; Spitaleri, L; Gini, G; Balducci, F; Masia, Mc; Leoni, Pietro; Olivieri, Attilio | |
| Reduced intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma. | 1-gen-2003 | Majolino, I; Arana, Mg; Riccardi, M; Locasciulli, A; Bacigalupo, A; Di Bartolomeo, P; Scime, R; Olivieri, Attilio; Narni, F; De Fabritiis, P; Corradini, P. | |
| In vivo T-cell depletion with low-dose alemtuzumab in non myeloablative allogeneic transplants is associated with a relatively rapid immunereconstitution and reduced incidence of graft-versus-host disease. | 1-gen-2003 | Dodero, A; Milani, R; Carrabba, M; Rizzo, E; Milanesi, M; Longoni, P; Montefusco, V; Farina, L; Lucesole, M; Leoni, Pietro; Olivieri, Attilio; Corradini, P. | |
| Efficacy of tumour-necrosis-factor alpha blockade with infliximab for the treatment of severe steroid-refractory acute graft-versus-host disease | 1-gen-2004 | Patriarca, F; Sperotto, A; Prosdocimo, S; Damiani, D; Morreale, G; Olivieri, Attilio; Bonifazi, F; Milone, G; Peccatori, J; Corradini, P; Fanin, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1475
Data di pubblicazione
- 2020 - 202581
- 2010 - 2019662
- 2000 - 2009566
- 1990 - 1999141
- 1981 - 198925
Editore
- BMJ / British Medical Journal Pub...1
- CSIRO Publishing:150 Oxford Stree...1
- Elsevier1
- Elsevier Science Limited:Oxford F...1
- Mary Ann Liebert Incorporated:2 M...1
- Oxford University Press:Journals ...1
- Parthenon Publishing:Richmond Hou...1
Rivista
- NEUROLOGICAL SCIENCES137
- BLOOD94
- BONE MARROW TRANSPLANTATION62
- HAEMATOLOGICA46
- ANNALS OF THE RHEUMATIC DISEASES43
- ITALIAN JOURNAL OF ANATOMY AND EM...40
- ANTICANCER RESEARCH33
- ITALIAN JOURNAL OF BIOCHEMISTRY31
- ACTA OPHTHALMOLOGICA27
- BIOCHIMICA CLINICA22
Keyword
- DBS4
- mortar3
- STN3
- brick2
- DBS STN2
- geopolymer2
- IAQ2
- language disorders2
- mechanical properties2
- P3002
Lingua
- eng954
- ita108
- ger1
- spa1
Accesso al fulltext
- no fulltext1473
- open1
- reserved1